Stay updated on ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial
Sign up to get notified when there's something new on the ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial page.

Latest updates to the ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, indicating a potential improvement or update in the content or functionality.SummaryDifference0.3%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check19 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
- Check26 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check33 days agoChange DetectedThe web page has been updated to reflect a new study on ALT-801 (pemvidutide) in healthy overweight and obese volunteers, including detailed descriptions of the study's phases and participant criteria. The previous study results and dates have been removed, indicating a shift in focus to the current study's design and objectives.SummaryDifference34%
- Check40 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
Stay in the know with updates to ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 Safety in Healthy Overweight and Obese Volunteers Clinical Trial page.